Exploring Inequities in Lung Cancer Management: A Comprehensive Spatio-Temporal Study of Multidisciplinary Meeting Presentations, Supportive Care Assessments, and Diagnostic Timeliness in Victoria - Report - MDSpire

Exploring Inequities in Lung Cancer Management: A Comprehensive Spatio-Temporal Study of Multidisciplinary Meeting Presentations, Supportive Care Assessments, and Diagnostic Timeliness in Victoria

  • By

  • Getayeneh Antehunegn Tesema

  • Rob G. Stirling

  • Zemenu Tadesse Tessema

  • Arul Earnest

  • February 27, 2026

  • 0 min

Share

Clinical Report: Exploring Inequities in Lung Cancer Management in Victoria

Overview

This study employs a joint Bayesian spatio-temporal modelling framework to analyze inequities in lung cancer management across Victoria, Australia. Key findings reveal significant geographic disparities in diagnostic timeliness, multidisciplinary meeting presentations, and supportive care assessments, highlighting areas for improvement in cancer care delivery.

Background

Lung cancer is a leading cause of cancer-related death in Australia, with poor outcomes primarily due to late-stage diagnoses. Timely access to diagnostic and supportive care services is essential for improving survival rates. The Victorian Lung Cancer Registry plays a crucial role in monitoring care quality through Clinical Quality Indicators, which are vital for identifying and addressing inequities in lung cancer management.

Data Highlights

No specific numerical data provided in the article.

Key Findings

  • Significant inter-institutional variation in MDM presentation rates (29.7–94%).
  • Supportive care screening rates varied widely (2–79%) across institutions.
  • Diagnostic timeliness showed notable geographic disparities.
  • Application of a joint Bayesian spatio-temporal framework revealed shared and specific trends in care indicators.
  • Identified persistent underperformance areas that require targeted interventions.

Clinical Implications

Healthcare providers should focus on standardizing practices related to MDM presentations and supportive care screenings to enhance equity in lung cancer management. Continuous monitoring through Clinical Quality Registries can inform strategies for improving care delivery and patient outcomes.

Conclusion

The study underscores the importance of addressing geographic and temporal inequities in lung cancer care to improve patient outcomes. Implementing targeted strategies based on these findings can enhance the quality of lung cancer management across Victoria.

References

  1. The ASCO Post, 2015 -- Highlights From the 2014 ASCO Quality Care Symposium
  2. The ASCO Post, 2021 -- Some Patients With Lung Cancer Report Feeling Uninformed About Their Disease, Uninvolved With Their Treatment
  3. Impact of Surgical Timing on Patient Outcomes in Early Stage Lung Cancer, 2023
  4. The ASCO Post, 2018 -- Disparities Found in Lung Cancer Care, Survival in United States vs England
  5. Australian Government Department of Health, 2025 -- The new National Lung Cancer Screening Program saves lives through early detection
  6. The Limbic, 2023 -- Aussie data show mortality benefit of lung cancer MDMs
  7. The new National Lung Cancer Screening Program saves lives through early detection | Australian Government Department of Health, Disability and Ageing
  8. Aussie data show mortality benefit of lung cancer MDMs
  9. Adjuvant Osimertinib in Resected EGFR-Mutant NSCLC Overall Survival Analysis of the ADAURA Trial - The ASCO Post

Original Source(s)

Related Content